INVESTORS

We welcome you to Sofwave’s Investor Relations page and would like to thank you for your interest in our company. Through this page you can find comprehensive and detailed information about our company and the performance of Sofwave.

The information on this page website is especially tailored for institutional investors, analysts and private shareholders as well as anyone interested in Sofwave’s performance.

Presentations

Video: Sofwave™ Investor Webinar with Dr. Goldberg

This exclusive webinar brings together our Sofwave™ management and investors with Dr. David Goldberg to discuss our unique technology, FDA indications, practice ROI and compares our proprietary SUPERB™ technology with existing treatments in the market.

Please note that the following webinar is in both Hebrew and English.

Press Releases

May 25, 2022
The medical aesthetic company provides voluntary data for the first quarter of 2022
Read the full article
May 17, 2022
Sofwave™ Technology Wins Major Beauty Awards – 2022 Adding To The 2021 Elle Award
Read the full article
Apr 26, 2022
SOFWAVE™ Is This Year’s NewBeauty Award Winner!
Read the full article
March 10, 2022
Sofwave Medical LTD reports financial results for the full year 2021 with accelerated growth in revenues and gross margin
Read the full article
December 12, 2021
Sofwave™ Awarded ELLE Magazine’s 2021 Future of Beauty Awards!
Read the full article
November 16, 2021
Sofwave™ Announces FDA clearance of New Lifting Indications for Eyebrow, Sub-Mental (beneath the chin) and Neck Facial Areas
Read the full article
September 9, 2021
Sofwave Medical Appoints Assaf Korner as Chief Financial Officer
Read the full article
September 5, 2021
Dr. Glynis Ablon Announces Top Trending Fine Lines and Wrinkle Reduction Treatment Now Offered at Ablon Skin Institute
Read the full article
September 5, 2021
Dr. Glynis Ablon Announces Top Trending Fine Lines and Wrinkle Reduction Treatment Now Offered at Ablon Skin Institute
Read the full article
August 30, 2021
Approval to Market Sofwave™ in South Korea
Read the full article
June 30, 2021
Sofwave™ Medical Raises $50M and Completes Initial Public Offering on the Tel Aviv Stock Exchange
Read the full article
April 20, 2021
Sofwave Receives Australian Regulatory Approval to Market SUPERB™, the Breakthrough Ultrasound Technology Treating Fine Lines & Wrinkles
Read the full article
March 2, 2021
Game-Changing Wrinkle Reduction Device Receives Key Regulatory Clearance in Canada
Read the full article

Sofwave Company Profile

Commitment & Passion

Commitment & Passion

Driven by experience and passion, Sofwave Medical is a fast-growing medical aesthetic technology innovator committed to developing cutting-edge technologies for the global aesthetic market.

Game-Changing Approach

Game-Changing Approach

Sofwave Medical’s breakthrough technology brings a new standard of care to aesthetic treatments, providing physicians with smart yet simple, effective and safe aesthetic treatments for their patients.

Heritage of Innovation

Heritage of Innovation

From key founders of the aesthetic industry, Sofwave Medical brings a novel approach to non-invasive skin treatments using proprietary Synchronous Ultrasound Parallel Beam Technology SUPERB™.

Sofwave TM Medical Completes Initial Public Offering on the Tel Aviv Stock Exchange
Video: Sofwave™ Mode of Action

Management

Dr. Shimon EckhouseRead More
Dr. Shimon Eckhouse
Chairman & Co-Founder
Louis ScafuriRead More
Louis Scafuri
CEO
Assaf KorenRead More
Assaf Korner
CFO
Genady NahshonRead More
Genady Nahshon
COO & Site Manager
Dr Ruthi AmirRead More
Dr. Ruthie Amir
Chief Medical Officer
Lina OmariRead More
Lina Omari
Chief Digital Officer
Ariel SverdlikRead More
Ariel Sverdlik
Co-Founder and CTO

    Contact Us

    Fill out the form below and we will reach out to you.

    © 2022 Sofwave TM